Mak J C W, Ho S P, Leung H C M, Cheung A H K, Law B K W, So L K Y, Chan J W M, Chau C H, Lam W K, Ip M S M, Chan-Yeung M
Division of Respiratory Medicine, Department of Medicine, The University of Hong Kong, Hong Kong, China.
Clin Exp Allergy. 2007 Aug;37(8):1150-7. doi: 10.1111/j.1365-2222.2007.02704.x.
Asthma is a disease associated with oxidative stress. The glutathione S-transferases (GST) are a group of enzymes that protect cells from oxidative stress. Functional genetic polymorphisms of GST genes (GSTT1, GSTM1 and GSTP1) have previously been reported.
To investigate the association of GST gene polymorphisms and its enzyme activity with the risk of asthma in Hong Kong Chinese adults.
An age- and smoking status-matched case-control study was carried out on 315 patients with asthma and 315 healthy controls. Genotyping was carried out on genomic DNA using the PCR and/or restriction fragment length polymorphism (PCR-RFLP). Plasma GST activity was measured by fluorometric assay.
The distribution of various genotypes or alleles of the GSTT1, GSTM1 and GSTP1 was not significantly different between patients with asthma and healthy controls. The GSTM1 null genotype was found to be protective from the development of asthma in atopic subjects (odds ratios 0.55, 95% confidence interval 0.34-0.90; P=0.017). However, there was no association between GSTT1 and GSTM1 null genotypes and enzyme activity. GSTP1 codon 105 Val variants led to reduced plasma GST activity in healthy controls. Asthma patients had elevated plasma GST activity compared with healthy controls irrespective of their genotypes (P<0.001).
Our data suggest that among atopic subjects, the GSTM1 null genotype is associated with a decreased risk for asthma despite increased level of plasma GST activity in asthma, but it could not distinguish whether this increase is a potentially protective compensatory effect or a pathogenic factor.
哮喘是一种与氧化应激相关的疾病。谷胱甘肽S-转移酶(GST)是一组保护细胞免受氧化应激的酶。此前已有关于GST基因(GSTT1、GSTM1和GSTP1)功能基因多态性的报道。
研究GST基因多态性及其酶活性与香港成年华人哮喘风险的关联。
对315例哮喘患者和315名健康对照者进行年龄和吸烟状况匹配的病例对照研究。使用聚合酶链反应(PCR)和/或限制性片段长度多态性(PCR-RFLP)对基因组DNA进行基因分型。通过荧光测定法测量血浆GST活性。
哮喘患者与健康对照者之间,GSTT1、GSTM1和GSTP1各种基因型或等位基因的分布无显著差异。发现GSTM1无效基因型对特应性受试者哮喘的发生具有保护作用(比值比0.55,95%置信区间0.34-0.90;P=0.017)。然而,GSTT1和GSTM1无效基因型与酶活性之间无关联。GSTP1第105位密码子Val变体导致健康对照者血浆GST活性降低。无论基因型如何,哮喘患者的血浆GST活性均高于健康对照者(P<0.001)。
我们的数据表明,在特应性受试者中,尽管哮喘患者血浆GST活性升高,但GSTM1无效基因型与哮喘风险降低相关,但无法区分这种升高是潜在的保护性代偿作用还是致病因素。